...
首页> 外文期刊>Cell Host & Microbe >Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.
【24h】

Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.

机译:耶尔森氏菌假结核效应因子YopJ破坏了Nod2 / RICK / TAK1途径并激活caspase-1诱导肠屏障功能障碍。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Yersinia pseudotuberculosis is an enteropathogenic bacteria that disrupts the intestinal barrier and invades its host through gut-associated lymphoid tissue and Peyer's patches (PP). We show that the Y.[NON-BREAKING SPACE]pseudotuberculosis effector YopJ induces intestinal barrier dysfunction by subverting signaling of the innate immune receptor Nod2, a phenotype that can be reversed by pretreating with the Nod2 ligand muramyl-dipeptide. YopJ, but not the catalytically inactive mutant YopJ(C172A), acetylates critical sites in the activation loops of the RICK and TAK1 kinases, which are central mediators of Nod2 signaling, and decreases the affinity of Nod2 for RICK. Concomitantly, Nod2 interacts with and activates caspase-1, resulting in increased levels of IL-1beta. Finally, IL-1beta within PP plays an essential role in inducing intestinal barrier dysfunction. Thus, YopJ alters intestinal permeability and promotes the dissemination of Yersinia as well as commensal bacteria by exploiting the mucosal inflammatory response
机译:伪结核耶尔森氏菌是一种肠致病细菌,它通过肠道相关的淋巴样组织和淋巴集结(PP)破坏肠屏障并侵入其宿主。我们显示,Y。[NON-BREAKING SPACE]假结核病效应因子YopJ通过破坏先天免疫受体Nod2的信号传导来诱导肠屏障功能障碍,后者可以通过用Nod2配体muramyl-dipeptide预处理来逆转其表型。 YopJ,而不是催化失活的突变型YopJ(C172A),不会使RICK和TAK1激酶的激活环中的关键位点乙酰化,这些激酶是Nod2​​信号传导的中心介质,并降低Nod2对RICK的亲和力。同时,Nod2与caspase-1相互作用并激活caspase-1,导致IL-1beta水平升高。最后,PP中的IL-1β在诱导肠屏障功能障碍中起着至关重要的作用。因此,YopJ通过利用粘膜炎症反应改变肠道通透性并促进耶尔森氏菌和共生细菌的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号